Riboflavin Encyclopedia — Scientific Background

What Is Riboflavin?

Riboflavin (CAS 83-88-5), also known as vitamin B2, lactoflavin, ovoflavin, or uroflavin, is a water-soluble vitamin with the molecular formula C₁₇H₂₀N₄O₆ and a molecular weight of 376.36 g/mol. The compound comprises a tricyclic, nitrogen-containing isoalloxazine ring system with a ribitol side-chain at N10, and is chemically defined as 7,8-dimethyl-10-(1-D-ribityl)-benzo[g]pteridin-2,4-dione. Riboflavin occurs as a yellow to orange-yellow crystalline powder that crystallizes in sharp, optically active needles and melts under decomposition at 275–282°C. The optical rotation is [α]D²⁵ = −112° to −122° at a concentration of 50 mg in 10 mL of 0.02 N alcoholic NaOH.

The Photosensitivity Challenge and liposomal Stabilization

Riboflavin is a highly photosensitive compound and is degraded in aqueous solution by several mechanisms. In alkaline solutions, light exposure decomposes riboflavin to lumiflavin (7,8,10-trimethylisoalloxazine), while in neutral or acidic solutions, the blue-fluorescent lumichrome (7,8-dimethylalloxazine) is formed—both photoproducts are biologically inactive. All operations with riboflavin solutions should be handled in the dark or under red light to prevent degradation. The light sensitivity of flavins has significant consequences for the stability of vitamin B2-containing foods; in milk stored in daylight, the riboflavin content decreases by more than 80% within hours.

Liposomal encapsulation provides a robust solution to this fundamental stability challenge. A study published in the Journal of Photochemistry and Photobiology B demonstrated that the apparent first-order rate constant for riboflavin photodegradation decreased linearly from 2.29 × 10⁻³ min⁻¹ to 1.73 × 10⁻³ min⁻¹ as phosphatidylcholine concentration increased from 12.15 to 14.85 mM, indicating that higher PC concentrations in liposomes lead to greater riboflavin stability. Fluorescence measurements indicate excited singlet state quenching and the formation of a charge-transfer complex between riboflavin and phosphatidylcholine. This results in electron transfer from PC to riboflavin, causing photoreduction and stabilization of the vitamin. The liposomal formulation thus provides intrinsic photoprotection without relying on additional light-blocking excipients.

Physiological Functions of Riboflavin

Riboflavin is important for the growth, development, and function of the cells in your body, and it also helps turn the food you eat into the energy you need. Key physiological roles include:

• Cofactor for FMN and FAD — Riboflavin is the precursor to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which serve as prosthetic groups in more than 100 enzymes in the plant and animal kingdoms. These flavoproteins belong to the enzymatic class of oxidoreductases and catalyze a wide range of oxidation-reduction reactions essential for life.

• Energy Metabolism — FAD and FMN are essential coenzymes in the mitochondrial electron transport chain (Complexes I and II), the TCA cycle (succinate dehydrogenase), and fatty acid β-oxidation (acyl-CoA dehydrogenase). Through these enzymes, riboflavin is indispensable for converting carbohydrates, fats, and proteins into ATP.

• Antioxidant Defense — FAD is a cofactor for Glutathione reductase, which regenerates reduced glutathione (GSH) from oxidized glutathione (GSSG). GSH is the body‘s master antioxidant, and riboflavin deficiency impairs the glutathione redox cycle, increasing oxidative stress.

• Homocysteine Regulation — FAD is a cofactor for methylenetetrahydrofolate reductase (MTHFR), the enzyme that converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. 5-Methyltetrahydrofolate is the methyl donor for the remethylation of homocysteine to methionine, a reaction catalyzed by methionine synthase (which also requires vitamin B12). Riboflavin deficiency can elevate homocysteine levels, a risk factor for cardiovascular disease.

• Red Blood Cell Production — Riboflavin is required for normal red blood cell production and function. Deficiency can contribute to anemia, particularly in individuals with certain genetic polymorphisms.

• Skin and Mucous Membrane Health — Riboflavin deficiency causes angular stomatitis (cracks at the corners of the mouth), cheilosis (chapped lips), glossitis (smooth, purplish-red tongue), and seborrheic dermatitis. These symptoms resolve rapidly with riboflavin repletion.

Metabolic Pathways and Mechanisms of Action

Flavin Cofactor Biosynthesis

Riboflavin is converted intracellularly to FMN by riboflavin kinase (RFK) and then to FAD by FAD synthetase (FLAD1). FMN and FAD are the active coenzyme forms that bind to flavoproteins. The isoalloxazine ring system of the flavin cofactor is responsible for its redox chemistry, undergoing reversible reduction between the oxidized flavoquinone form and the reduced flavohydroquinone (leucobase) form. This reversible redox chemistry enables flavoproteins to participate in one- and two-electron transfer reactions.

Cellular Uptake and Transport

Riboflavin absorption occurs through two mechanisms: a saturable active component that dominates at near-physiological vitamin concentrations and a passive component that is revealed at higher concentrations. The active transport is mediated by riboflavin transporters (RFVT1, RFVT2, RFVT3) encoded by the SLC52A1, SLC52A2, and SLC52A3 genes. Riboflavin transporter deficiency is a genetic disorder that causes neurological symptoms including hearing loss, weakness, and sensory ataxia. Liposomal encapsulation bypasses the saturable active transport pathway by utilizing lipid-mediated absorption mechanisms.

The Bioavailability Challenge

Despite its essential physiological functions, conventional oral riboflavin presents significant bioavailability challenges. The body cannot absorb more than approximately 27 mg of riboflavin at a time, and excess riboflavin is excreted in the urine. The hydrophilic nature of riboflavin causes rapid clearance from the bloodstream and low intracellular absorption, reducing its therapeutic efficacy. Additionally, riboflavin is highly photosensitive and is irreversibly degraded by light to biologically inactive photoproducts, limiting its stability in formulated products.

These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. Liposomal riboflavin formulations achieve entrapment efficiencies of 26–42% using standard preparation methods and up to 78% with optimized sucrose-lipid ratios, while significantly enhancing photostability and cellular delivery.

Liposomal Riboflavin

Liposomal encapsulation of riboflavin provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the riboflavin molecule, forming a protective shell that enhances stability, bioavailability, and cellular uptake. This delivery system:

• Achieves entrapment efficiencies of 26–42% (standard) to 78% (optimized sucrose-lipid ratio)

• Significantly enhances photostability, with degradation rate constants decreasing linearly with increasing phosphatidylcholine concentration

• Forms a charge-transfer complex between riboflavin and phosphatidylcholine, causing photoreduction and stabilization

• Bypasses saturable active transport mechanisms through lipid-mediated absorption

• Protects riboflavin from light-induced degradation to lumiflavin and lumichrome

Clinical Evidence

Migraine Prophylaxis

High-dose riboflavin has demonstrated efficacy in reducing migraine frequency. A randomized controlled trial demonstrated that riboflavin at 400 mg/day reduced migraine frequency by more than 50% in adults. Riboflavin is thought to work by improving mitochondrial energy metabolism, which is impaired in migraine patients. The American Headache Society and the Canadian Headache Society have both issued guidelines recommending riboflavin for migraine prophylaxis.

MTHFR Polymorphisms and Homocysteine

Riboflavin is a cofactor for MTHFR, and individuals with the MTHFR 677C→T polymorphism have reduced enzyme activity that can be partially compensated by adequate riboflavin status. Clinical studies have demonstrated that riboflavin supplementation lowers homocysteine levels in individuals with this polymorphism, supporting its role in cardiovascular risk management.

Riboflavin Transporter Deficiency

Riboflavin transporter deficiency (Brown-Vialetto-Van Laere syndrome) is a rare genetic disorder caused by mutations in SLC52A2 or SLC52A3. High-dose riboflavin supplementation (up to 200 mg/day) has been shown to improve neurological symptoms in affected individuals, demonstrating the therapeutic potential of riboflavin in genetic transporter deficiencies.

Safety and Regulatory

Riboflavin is generally well tolerated. It is a water-soluble vitamin, and excess amounts are excreted in the urine, giving it a bright yellow color. No tolerable upper intake level (UL) has been established for riboflavin due to its low toxicity. Riboflavin is considered safe even at high doses.

Regulatory Status:

• United States — Riboflavin is regulated as a dietary supplement ingredient and food additive. It is Generally Recognized As Safe (GRAS) for use in food and dietary supplements. It is used as a food colorant (E101) and is permitted in food fortification. It is monographed in the USP with an assay specification of 98.0%–102.0% on dried basis.

• European Union — Riboflavin is authorized as a food additive (E101) and is permitted for use in food supplements in EU member states. It is used to impart yellow color to foodstuffs and is authorized for use in foods for particular nutritional uses.

• Global Standards — Riboflavin is monographed in the USP, European Pharmacopoeia, and Japanese Pharmacopoeia. The product is available with Halal and Kosher certifications.

Precautions: Individuals with known hypersensitivity to riboflavin should avoid supplementation. Pregnant or lactating women and children should consult a healthcare professional before use. Riboflavin may interact with certain medications, including anticholinergic drugs, tricyclic antidepressants, and probenecid. Riboflavin supplementation may interfere with certain laboratory tests, including fluorometric determinations and urobilinogen measurements.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

109$/KG

99$/KG